Laser eye treatment timing for certain glaucoma or eye pressure
Part of Eyes & vision clinical trials.
This Phase 3 study tests how best to use a laser treatment (SLT) for people with high eye pressure or mild-to-moderate primary open-angle glaucoma. It aims to find the best way to lower eye pressure and protect vision while comparing treatment approaches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 or older and generally healthy enough for study visits
- Have qualifying eye conditions in each eye: high-risk eye pressure, mild glaucoma, or moderate glaucoma
- Your vision in each eye must be 20/200 or better
- Do not have long-term past use of pressure-lowering eye drops for more than 6 total months in the last 5 years
- No past eye laser treatment for pressure or any glaucoma surgery, and no eye surgery in the past 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new way of doing laser treatment for open-angle glaucoma versus the standard method. The goal is to see which approach works better at lowering eye pressure and protecting vision.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
This trial compares two first treatments—laser therapy (SLT) or daily eye drops (latanoprost)—to lower eye pressure in people newly diagnosed with open-angle glaucoma or high eye pressure. It aims to find which approach works better as an initial therapy.
This study tests a newer type of laser treatment for glaucoma, called direct selective laser trabeculoplasty (DSLT), in people who have already had a standard SLT laser before. It aims to see if DSLT can further lower eye pressure, which may help protect your vision.
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
This trial tests a new laser treatment called DSLT for people with normal-tension glaucoma, a type of glaucoma where eye pressure is normal but vision is still damaged. It aims to lower eye pressure and help preserve vision. The study is specifically for people of Asian descent.
Hear when a new Glaucoma and Ocular Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.